Abstract 6844: Transvenous High-Intensity Ultrasound Catheter Ablation Achieves Significant Septal Reduction in Swine
Abstract
Background: High-intensity ultrasound (HIU) catheter ablation produces deeper lesions than radiofrequency and may serve as a new modality for interventricular septal (IVS) reduction in hypertrophic cardiomyopathy (HCM). Hypothesis: Transvenous HIU catheter ablation of the basal IVS will result in significant septal thickness reduction at 1- and 3-months in healthy swine. Methods: Twelve 40-45 kg healthy swine underwent contact sensing-guided HIU catheter ablation via femoral venous access targeting the RV side of the IVS (Fig A,B). Each swine underwent 8 HIU sonications (10W acoustic power for 90sec). Electroanatomic mapping was performed pre- and post-ablation. Cardiac MRI (Fig C) was performed in a subset pre- (n=9) and immediately post-ablation (n=9) and at 1-month (n=5) or 3-months (n=7). Animals were euthanized immediately after the end-point MRI and lesions were further assessed by pathology (Fig D). IVS thickness was measured in short axis and compared to the lateral wall (LW) thickness to account for swine growth. Mean ± standard deviation is reported. Group comparisons were performed using unpaired, two-tailed homoscedastic t-tests for continuous variables and chi-squared tests for categorical outcomes. Results: Cardiac MRI showed significant septal reduction in systole (11.2±1.3 mm pre- to 5.7±0.6 mm 1-month and 4.0±1.4 mm 3-months post-ablation) and diastole (8.9±1.1 mm pre- to 5.5±0.7 mm at 1-month, and 3.7±0.9 mm at 3-months post-ablation), p<0.01 for all (Fig E). Normalized to the LW, systolic IVS was reduced by 51±4% at 1-month and 63±9% at 3-months and diastolic IVS reduced by 44±7% at 1-month and 67±11% at 3-months. There was no significant septal thickening immediately post-ablation. A non-significant trend toward LVEF reduction was observed immediately post-procedure (LVEF 52±5% pre- to 49±4% post-ablation, p=0.07) that recovered at 1- and 3-months post-ablation. Septal reduction was confirmed on gross pathology (IVS/LW of 57±10% at 1-month and 76±9% at 3-months post-ablation) with fibrosis on H&E and Masson’s trichrome histology. Post-ablation voltage mapping showed new areas of low RV IVS unipolar voltage in all swine with no intergroup differences, and a non-significant trend towards longer AH/HV intervals. Transient atrio-ventricular block (AVB) occurred in one swine. No ventricular septal defects, permanent AVB, pericardial effusions, or mortalities occurred. Conclusion: Transvenous HIU ablation results in significant, durable septal reduction in healthy swine with an acceptable safety profile. This novel ablation modality is a promising, minimally invasive alternative to traditional septal reduction therapies for HCM. In the absence of validated swine models of obstructive HCM, first-in-human studies will likely be required to confirm reduction in left ventricular outflow tract obstruction.